Advertisement
U.S. markets close in 1 hour 33 minutes
  • S&P 500

    5,253.83
    +5.34 (+0.10%)
     
  • Dow 30

    39,790.07
    +29.99 (+0.08%)
     
  • Nasdaq

    16,381.11
    -18.42 (-0.11%)
     
  • Russell 2000

    2,124.79
    +10.44 (+0.49%)
     
  • Crude Oil

    83.05
    +1.70 (+2.09%)
     
  • Gold

    2,242.40
    +29.70 (+1.34%)
     
  • Silver

    24.99
    +0.24 (+0.96%)
     
  • EUR/USD

    1.0794
    -0.0035 (-0.32%)
     
  • 10-Yr Bond

    4.2040
    +0.0080 (+0.19%)
     
  • GBP/USD

    1.2623
    -0.0015 (-0.12%)
     
  • USD/JPY

    151.3910
    +0.1450 (+0.10%)
     
  • Bitcoin USD

    70,893.02
    +2,259.53 (+3.29%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Insiders Roundup: NuStar Energy, Opko Health, Alphabet

- By Tiziano Frateschi

The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to "$200,000+," the duration to "April 2017" and All Insider Sales to "$5,000,000+."


According to the above filters, the following are trades from company insiders this week.

NuStar Energy LP (NS) Directors William E. Greehey and Dan J. Hill bought 328,600 shares for $46.35 per share on April 12. Since then, the stock price has increased to $47.39.

The company is engaged in refining, marketing and operating petroleum product terminals and petroleum liquids pipelines.

The company has an institutional ownership of 60.21% and insider ownership of 4.66%.

Over the last 12 months, the stock price has risen by 8% and is now trading with a price-book (P/B) ratio of 2.33. The price is 14.02% below its 52-week high and 14.59% above its 52-week low.

Agenus Inc. (AGEN) Chairman and CEO Garo H. Armen bought 100,000 shares for $3.35 per share on April 12. Since then, the stock price has dropped to $3.47.

The company is engaged in discovery and development of revolutionary new treatments that engage the body's immune system to benefit cancer patients.

The company has an institutional ownership of 41.69% and insider ownership of 2.20%.

Over the last 12 months, the stock price has dropped by 25%, and the price is 56.74% below its 52-week high and 9.09% above its 52-week low.

OPKO Health Inc. (OPK) CEO, Chairman and 10% owner Phillip Frost, M.D., et al., bought 33,000 shares for $7.60 per share on April 10. Since then, the stock price hasn't faced a relevant change and is now at $7.62.

It is a diversified health care company. The company's operating business segments are diagnostics and pharmaceutical.

The company has an institutional ownership of 21.53% and insider ownership of 6.83%.

Over the last 12 months, the stock price has dropped by 30% and is now trading with a P/B ratio of 1.99. The price is 37.86% below its 52-week high and 5.89% above its 52-week low.

Pulse Biosciences Inc. (PLSE) 10% owner Robert W. Duggan bought 191,464 shares for $19.75 per share on April 10. Since then, the stock price has risen to $23.26.

It is a development stage medical device company using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling or NPES for biomedical applications.

The company has an institutional ownership of 1.61% and insider ownership of 18.27%.

Over the last 12 months, the stock price has risen by 473% and is now trading with a P/B ratio of 12.59. The price is 33.51% below its 52-week high and 492.80% above its 52-week low.

Most important sales of the week

McCormick & Co. Inc. Non-Voting (MKC) Director and 10% owner Alan D. Wilson sold 207,531 shares for $99.83 per share on April 12. Since then, the stock price has declined to $99.19.

The company manufactures, markets and distributes spices, seasoning mixes, condiments and other flavorful products to the entire food industry retail outlets, food manufacturers and food service businesses.

The company has an institutional ownership of 75.06% and insider ownership of 1.42%.

Over the last 12 months, the stock price has risen by 3% and is now trading with a P/B ratio of 7.24 The price is 7.42% below its 52-week high and 12.64% above its 52-week low.

ServiceNow Inc. (NOW) Director Frederic B. Luddy sold 102,000 shares for $84.88 per share on April 3 and April 5. Since then, the stock price didn't have any change and is now $84.64.

The company is a provider of cloud-based solutions that define, structure, manage and automate services across the enterprise. Its services include a suite of applications built on proprietary platform.

The company has an institutional ownership of 93.07% and insider ownership of 7.34%.

Over the last 12 months, the stock price has risen by 34% and is now trading with a P/B ratio of 36.56. The price is 10.88% below its 52-week high and 37.54% above its 52-week low.

Alphabet Inc. Class C (GOOG) Senior Vice President Corporate Development David C. Drummond sold 2,000 shares for $830.20 per share on April 12. Since then, the stock price has declined to $823.56.

The company through its subsidiary Google Inc. is engaged in improving the ways people connect with information and products including Search, Android, YouTube, Apps, Maps and Ads. It also produces internet-connected home devices and provides internet services.

The company has an institutional ownership of 34.23% and insider ownership of 0.36%.

Over the last 12 months, the stock price has risen by 10% and is now trading with a P/B ratio of 4.18. The price is 3.42% below its 52-week high and 24.28% above its 52-week low.

Wells Fargo & Co. (WFC) 10% owner Berkshire Hathaway Inc. (BRK-A)(BRK-B) sold 7,134,447 shares for $53.81 per share on April 12. Since then, the stock price has dropped to $51.35.

It is a diversified financial services company. It provides retail, corporate and commercial banking services through banking stores and offices, the internet and other distribution channels to individuals, businesses and institutions.

The company has an institutional ownership of 76.02% and insider ownership of 0.06%.

Over the last 12 months, the stock price has risen by 8% and is now trading with a P/B ratio of 1.52. The price is 11.45% below its 52-week high and 21.97% above its 52-week low.

Disclosure: I do not own any shares of any stocks mentioned in this article.

Start a free seven-day trial of Premium Membership to GuruFocus.

This article first appeared on GuruFocus.


Advertisement